| Note |
This man is an island. He is a phobic patient, living alone with his fear and anxiety. Nardil, a proven MAO inhibitor, will help bring him back to the mainland of society. The evidence of Nardil's effectiveness in phobic states is increasing with usage. One patient, 26 years of age, had suffered from phobic anxiety for over ten years; a number of treatments had failed to alleviate his condition. "Phenelzine was started in doses of 15 mg t.d.s., and within two weeks there has been a complete change in his behaviour. He looked relaxed, did not complain, talked freely and was able to go to the town, which he had not been able to do for over twelve months." In 1970, the Practitioner published its first major review of psychotropic drugs for three years; Nardil was selected as the most valuable drug for combination therapy in the treatment of phobic states. "And patients with atypical depression, particularly those in whom phobic anxiety symptoms are prominent, will respond dramatically and almost specifically to the combination of an MAO inhibitor, such as phenelzine, with chlordiazepoxide or diazepam." |
